JP2000212027A - Preparation for external use for skin - Google Patents

Preparation for external use for skin

Info

Publication number
JP2000212027A
JP2000212027A JP11016536A JP1653699A JP2000212027A JP 2000212027 A JP2000212027 A JP 2000212027A JP 11016536 A JP11016536 A JP 11016536A JP 1653699 A JP1653699 A JP 1653699A JP 2000212027 A JP2000212027 A JP 2000212027A
Authority
JP
Japan
Prior art keywords
extract
acid
skin
salts
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11016536A
Other languages
Japanese (ja)
Other versions
JP3513873B2 (en
Inventor
Hiroshi Hoshino
拓 星野
Tomonori Hata
友紀 畑
Shizuka Uehara
静香 上原
Ichiro Sasaki
一郎 佐々木
Kenichi Nagamine
賢一 永峰
Takashi Kito
孝 木藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kose Corp
Nichirei Corp
Original Assignee
Kose Corp
Nichirei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corp, Nichirei Corp filed Critical Kose Corp
Priority to JP01653699A priority Critical patent/JP3513873B2/en
Publication of JP2000212027A publication Critical patent/JP2000212027A/en
Application granted granted Critical
Publication of JP3513873B2 publication Critical patent/JP3513873B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a preparation for external use for skin sufficiently exhibiting the characteristic drug action of cell activation agent and moisture-retaining agent and having excellent skin aging prevention effect, skin roughening prevention effect and moisture-retaining effect by making the preparation include and acerola extract, a cell activation agent and a moisture retaining agent. SOLUTION: The objective preparation contains (A) an acerola extract and (B) a cell activation agent (e.g. deoxyribonucleic acid, adenosine triphosphate, serum deproteinizing extract and placenta extract) and/or a moisture-retaining agent (e.g. hyaluronic acid, condroitinsulfuric acid, and dermatansulfuric acid). The extract of the component A is produced by extracting a fruit of acerola which is a fruit tree belonging to the genus Malpighia with a proper extraction solvent at low temperature, normal temperature or under heating. The preferable compounding amount of the above component is 0.00005-5 wt.% for the component A in terms of dried solid, and 0.00001-10 wt.% for the sell activation agent and 0.00001-70 wt.% for the moisture-retaining agent of the component B.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、アセロラ抽出物と
特定の薬効成分とを配合した皮膚外用剤に関し、更に詳
細には、優れた皮膚老化防止や肌荒れ改善効果並びに保
湿効果を有し、肌にはりやつやを与えることができる皮
膚外用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an external preparation for skin containing an acerola extract and a specific medicinal ingredient, and more particularly, it has an excellent effect of preventing skin aging, improving skin roughness, and moisturizing effect. The present invention relates to a skin external preparation capable of giving a bite and gloss.

【0002】[0002]

【従来の技術】従来より、乳液、クリーム、化粧水、パ
ック、分散液、洗浄料、軟膏剤、クリーム剤、外用液剤
等の皮膚外用剤には、これらに所定の薬効を付与するこ
とを目的として細胞賦活剤や保湿剤などの薬効成分が加
えられている。例えば、肌荒れ改善、皮膚老化防止、細
胞賦活の他、切創やひげそり後の傷の治療、ひび、あか
ぎれ、ただれ、痔疾、火傷等の改善等の創傷治療を目的
に、人参抽出物、シコン抽出物、胎盤抽出物、牛血液除
蛋白質、発酵代謝産物等の薬効成分が配合されている。
2. Description of the Related Art Conventionally, an external preparation for skin such as milky lotion, cream, lotion, pack, dispersion, detergent, ointment, cream, liquid for external use, etc. is intended to impart a predetermined medicinal effect to them. Pharmaceutical ingredients such as cell activators and humectants are added. For example, to improve skin roughness, prevent skin aging, activate cells, treat wounds after cutting and shaving, and treat wounds such as cracks, irritations, sores, hemorrhoids, burns, etc. , A placenta extract, bovine blood deproteinization, and fermentation metabolites.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、細胞賦
活剤や保湿剤を配合した皮膚外用剤では、細胞賦活剤や
保湿剤の効果が十分でなかったり、あるいはその薬効を
得るのに十分な量を配合すると安定性に欠けたり使用感
が損なわれるなどの問題点があった。本発明はかかる問
題点を解消した皮膚外用剤を提供することを目的とす
る。
However, in a skin external preparation containing a cell activator or a humectant, the effect of the cell activator or the humectant is not sufficient, or an amount sufficient to obtain the medicinal effect is not sufficient. When blended, there are problems such as lack of stability and impaired usability. An object of the present invention is to provide a skin external preparation that has solved such problems.

【0004】[0004]

【課題を解決するための手段】本発明者らは、細胞賦活
剤や保湿剤の薬効成分の効果を向上させるべく鋭意検討
を行った結果、アセロラ抽出物と細胞賦活剤及び/又は
保湿剤とを組み合わせることによって、細胞賦活剤や保
湿剤の本来の有する薬効成分の作用が十分発揮されるこ
とを見出し、本発明を完成した。すなわち、本発明は、
(A)アセロラ抽出物、並びに(B)細胞賦活剤及び/
又は保湿剤を含有する皮膚外用剤である。
Means for Solving the Problems The present inventors have conducted intensive studies to improve the effects of the medicinal components of the cell activator and the humectant. As a result, the acerola extract and the cell activator and / or the humectant were used. It has been found that by combining the above, the action of the medicinal component originally possessed by the cell activator and the humectant is sufficiently exhibited, and the present invention has been completed. That is, the present invention
(A) an acerola extract, and (B) a cell activator and / or
Or a skin external preparation containing a moisturizer.

【0005】[0005]

【発明の実施の形態】本発明の皮膚外用剤の(A)成分
であるアセロラ抽出物は、マルピギア属(Malpighia)
の果樹であるアセロラ(Acerola、学名 Malpighia emar
ginata DC;アセロラの学名は、時代、地域、及び研究
者により論文等への記載が異なっている。従来はMalpig
hia punicifolia L.及びMalpighia glabra L.がアセロ
ラの学名として混同されて使われているが、現在では、
1980年にSteven Nagyらによって編集された「TROPI
CAL AND SUBTROPICAL FRUITS」で記載されている Malpig
hia emarginata DCが最も適当である。)の果実から抽
出溶媒を用いて抽出する。その抽出処理は、特に限定さ
れないが、適当な溶媒を用いて低温又は室温ないし加温
下で抽出される。
BEST MODE FOR CARRYING OUT THE INVENTION The acerola extract, which is the component (A) of the external preparation for skin of the present invention, comprises Malpighia.
Acerola (Acerola, scientific name Malpighia emar)
ginata DC; Acerola's scientific name differs in writing in papers and the like depending on the age, region, and researchers. Previously Malpig
hia punicifolia L. and Malpighia glabra L. are confused and used as acerola scientific names.
"TROPI" edited by Steven Nagy et al. In 1980
CAL AND SUBTROPICAL FRUITS "
hia emarginata DC is most suitable. ) The fruit is extracted using an extraction solvent. The extraction treatment is not particularly limited, but the extraction is carried out at a low temperature or at room temperature or with a suitable solvent.

【0006】上記の抽出溶媒としては、例えば水;メチ
ルアルコール、エチルアルコール等の低級1価アルコー
ル;グリセリン、プロピレングリコール、1,3−ブチ
レングリコール等の液状多価アルコール等の1種または
2種以上を用いることができる。好ましい抽出方法の例
としては、精製水を用い、低温下にて抽出を行なった後
濾過し、更に20〜70%(W/W)の濃度になるよう
に1,3−ブチレングリコールを混合し、再び濾過を行
なう方法が挙げられる。
Examples of the above-mentioned extraction solvent include one or more of water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; and liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol. Can be used. As an example of a preferable extraction method, after performing extraction at a low temperature using purified water, filtration is performed, and 1,3-butylene glycol is further mixed to a concentration of 20 to 70% (W / W). And a method of performing filtration again.

【0007】本発明の皮膚外用剤におけるアセロラ抽出
物の配合量(含有量)は、乾燥固形分として好ましくは
0.00005〜5重量%(以下、「重量%」を単に
「%」で示す)であり、より好ましくは0.0005か
ら1%である。このアセロラ抽出物の含有量が0.00
005%より少ないと十分な効果が得られないことがあ
り、また、5%を超えて配合してもそれ以上の効果の増
大は見られない。
The amount (content) of the acerola extract in the external preparation for skin of the present invention is preferably 0.00005 to 5% by weight as dry solid content (hereinafter, "% by weight" is simply indicated by "%"). And more preferably 0.0005 to 1%. The content of this acerola extract is 0.00
If the amount is less than 005%, a sufficient effect may not be obtained, and if the amount exceeds 5%, no further increase in the effect is observed.

【0008】また、本発明の皮膚外用剤の(B)成分と
しては細胞賦活剤及び/又は保湿剤から選ばれるもので
ある。具体的には、それぞれ以下に示すものが挙げられ
る。細胞賦活剤としては、デオキシリボ核酸及びその
塩、アデノシン三リン酸、アデノシン一リン酸などのア
デニル酸誘導体及びそれらの塩、リボ核酸及びその塩、
サイクリックAMP、サイクリックGMP、フラビンア
デニンヌクレオチド、グアニン、アデニン、シトシン、
チミン、キサンチン及びそれらの誘導体であるカフェイ
ン、テオフェリン並びにそれらの塩等の核酸関連物質、
ブタ、ウシ等の胎盤抽出物、幼牛血液抽出液、血清除蛋
白抽出物、脾臓抽出物、トリ等の卵成分、鶏冠抽出物、
貝殻抽出物、貝肉抽出物、ローヤルゼリー、シルクプロ
テイン及びその分解物又はそれらの誘導体、ヘモグロビ
ン又はその分解物、ラクトフェリン又はその分解物、イ
カスミ等の軟体動物抽出物、魚肉抽出物等、哺乳類、鳥
類、貝類、昆虫類、魚類、甲殻類等の動物由来の抽出
物、酵母抽出物、乳酸菌抽出物、ビフィズス菌抽出物等
の発酵代謝産物から選ばれる微生物由来の抽出物が挙げ
られる。
The component (B) of the external preparation for skin of the present invention is selected from a cell activator and / or a humectant. Specifically, the following are shown, respectively. As a cell activator, deoxyribonucleic acid and salts thereof, adenosine triphosphate, adenylic acid derivatives such as adenosine monophosphate and salts thereof, ribonucleic acid and salts thereof,
Cyclic AMP, cyclic GMP, flavin adenine nucleotide, guanine, adenine, cytosine,
Thymine, xanthine and their derivatives caffeine, theophylline and nucleic acid related substances such as their salts,
Placenta extracts of pigs, cows, etc., calf blood extracts, serum deproteinized extracts, spleen extracts, egg components such as birds, cockscomb extracts,
Mammals and birds such as shellfish extract, shellfish extract, royal jelly, silk protein and its degradation products or their derivatives, hemoglobin or its degradation products, lactoferrin or its degradation products, mollusk extracts such as squid, fish meat extracts, etc. And extracts derived from microorganisms selected from fermentation metabolites such as extracts from animals such as shellfish, insects, fish, and crustaceans, yeast extracts, lactic acid bacteria extracts, and bifidobacteria extracts.

【0009】更に細胞賦活剤として、レチノール及びそ
の誘導体(パルミチン酸レチノール、酢酸レチノール
等)、レチナール及びその誘導体、デヒドロレチナー
ル、カロチン等のカロチノイド等のビタミンA類、チア
ミン類(チアミン塩酸塩、チアミン硫酸塩等)、リボフ
ラビン類(リボフラビン、酢酸リボフラビン等)、ピリ
ドキシン類(塩酸ピリドキシン、ピリドキシンジオクタ
ノエート等)、フラビンアデニンヌクレオチド、シアノ
コバラミン、葉酸類、ニコチン酸類(ニコチン酸アミ
ド、ニコチン酸ベンジル等)、コリン類等のビタミンB
類、アスコルビン酸及びその誘導体等のビタミンC類、
アスパラガス抽出物、アンズ抽出物、イチョウ抽出物、
オタネニンジン抽出物、オオムギ抽出物、オウバク抽出
物、オレンジ抽出物、キュウリ抽出物、キウイ抽出物、
シイタケ抽出物、スギナ抽出物、センブリ抽出物、タイ
ソウ抽出物、トウキンセンカ抽出物、トウガラシ抽出
物、ニンニク抽出物、ニンジン抽出物、ブクリョウ抽出
物、ブナの芽抽出物、モモ抽出物、レタス抽出物、レモ
ン抽出物、ユーカリ抽出物、霊芝抽出物、ローズマリー
抽出物、ヒノキチオール、セファランチン、ブドウ種子
油等の植物由来の抽出物、α−及びγ−リノレン酸、エ
イコサペンタエン酸及びそれらの誘導体、エストラジオ
ール及びその誘導体並びにそれらの塩、グリコール酸、
コハク酸、乳酸、サリチル酸等の有機酸及びそれらの誘
導体並びにそれらの塩等が挙げられる。上記に挙げた細
胞賦活剤は一種又は二種以上を適宜選択して配合するこ
とができる。
As cell activators, vitamin A such as retinol and its derivatives (retinol palmitate, retinol acetate, etc.), retinal and its derivatives, carotenoids such as dehydroretinal and carotene, and thiamines (thiamine hydrochloride, thiamine sulfate) Salts), riboflavins (riboflavin, riboflavin acetate, etc.), pyridoxines (pyridoxine hydrochloride, pyridoxine dioctanoate, etc.), flavin adenine nucleotides, cyanocobalamin, folic acids, nicotinic acids (nicotinamide, benzyl nicotinate, etc.), Vitamin B such as choline
C, vitamin Cs such as ascorbic acid and its derivatives,
Asparagus extract, apricot extract, ginkgo extract,
Panax ginseng extract, barley extract, oak extract, orange extract, cucumber extract, kiwi extract,
Shiitake extract, horsetail extract, Japanese cabbage extract, Japanese radish extract, Calendula extract, Pepper extract, Garlic extract, Carrot extract, Bulberry extract, Beech bud extract, Peach extract, Lettuce extract , Lemon extract, eucalyptus extract, ganoderma extract, rosemary extract, hinokitiol, cepharanthin, grape seed oil and other plant-derived extracts, α- and γ-linolenic acid, eicosapentaenoic acid and derivatives thereof, Estradiol and its derivatives and their salts, glycolic acid,
Organic acids such as succinic acid, lactic acid, and salicylic acid, and derivatives thereof, and salts thereof, and the like. One or more of the above-mentioned cell activators can be appropriately selected and blended.

【0010】上記のアスコルビン酸及びその誘導体等の
ビタミンC類としては、L−アスコルビン酸、パルミチ
ン酸L−アスコルビル、ジパルミチン酸L−アスコルビ
ル、イソパルミチン酸L−アスコルビル、ジイソパルミ
チン酸L−アスコルビル、テトライソパルミチン酸L−
アスコルビル、ステアリン酸L−アスコルビル、ジステ
アリン酸L−アスコルビル、イソステアリン酸L−アス
コルビル、ジイソステアリン酸L−アスコルビル、ミリ
スチン酸L−アスコルビル、ジミリスチン酸L−アスコ
ルビル、イソミリスチン酸L−アスコルビル、ジイソミ
リスチン酸L−アスコルビル、オレイン酸L−アスコル
ビル、ジオレイン酸L−アスコルビル、2−エチルヘキ
サン酸L−アスコルビル、 L−アスコルビン酸リン酸
エステルナトリウム、L−アスコルビン酸リン酸エステ
ルカリウム、L−アスコルビン酸リン酸エステルマグネ
シウム、L−アスコルビン酸リン酸エステルカルシウ
ム、L−アスコルビン酸リン酸エステルアルミニウム、
L−アスコルビン酸硫酸エステルナトリウム、L−アス
コルビン酸硫酸エステルカリウム、L−アスコルビン酸
硫酸エステルマグネシウム、L−アスコルビン酸硫酸エ
ステルカルシウム、L−アスコルビン酸硫酸エステルア
ルミニウム、L−アスコルビン酸ナトリウム、L−アス
コルビン酸カリウム、L−アスコルビン酸マグネシウ
ム、L−アスコルビン酸カルシウム、L−アスコルビン
酸アルミニウム等が挙げられる。
The above-mentioned vitamin Cs such as ascorbic acid and its derivatives include L-ascorbic acid, L-ascorbyl palmitate, L-ascorbyl dipalmitate, L-ascorbyl isopalmitate, and L-ascorbyl diisopalmitate. , Tetraisopalmitic acid L-
Ascorbyl, L-ascorbyl stearate, L-ascorbyl distearate, L-ascorbyl isostearate, L-ascorbyl diisostearate, L-ascorbyl myristate, L-ascorbyl dimyristate, L-ascorbyl isomyristate, diisomyristate L-ascorbyl, L-ascorbyl oleate, L-ascorbyl dioleate, L-ascorbyl 2-ethylhexanoate, sodium L-ascorbate, potassium L-ascorbate, potassium L-ascorbate Magnesium, calcium L-ascorbate, aluminum phosphate L-ascorbate,
Sodium L-ascorbate, potassium L-ascorbate, magnesium L-ascorbate, calcium L-ascorbate, aluminum L-ascorbate, aluminum L-ascorbate, L-ascorbate Potassium, magnesium L-ascorbate, calcium L-ascorbate, aluminum L-ascorbate and the like.

【0011】これら細胞賦活剤のうち、特に好ましいも
のとしては、デオキシリボ核酸及びその塩、アデノシン
三リン酸及びその塩、血清除蛋白抽出物、胎盤抽出物、
酵母抽出物、オタネニンジン抽出物、ローズマリー抽出
物、トウガラシ抽出物、イチョウ抽出物、オオムギ抽出
物、ローヤルゼリー抽出物、乳酸、コハク酸及びそれら
の誘導体並びにそれらの塩が挙げられる。
Of these cell activators, particularly preferred are deoxyribonucleic acid and its salts, adenosine triphosphate and its salts, serum deproteinized extract, placenta extract,
Examples include yeast extract, Panax ginseng extract, rosemary extract, capsicum extract, ginkgo extract, barley extract, royal jelly extract, lactic acid, succinic acid and derivatives thereof, and salts thereof.

【0012】保湿剤としては、アルカリ単純温泉水、深
層水、ヒアルロン酸、コンドロイチン硫酸、デルマタン
硫酸、ヘパラン硫酸、ヘパリン及びケラタン硫酸などの
ムコ多糖類またはそれらの塩、コラーゲン、エラスチ
ン、ケラチンなどのタンパク質またはそれらの誘導体並
びにそれらの塩、大豆及び卵由来のリン脂質、糖脂質、
セラミド、ムチン、ハチミツ、エリスリトール、マルト
ース、マルチトール、キシリトール、キシロース、ペン
タエリスリトール、フルクトース、デキストリン及びそ
の誘導体、マンニトール、ソルビトール、イノシトー
ル、トレハロース、ブドウ糖等の糖類、尿素、アスパラ
ギン、アスパラギン酸、アラニン、アルギニン、イソロ
イシン、オルチニン、グルタミン、グリシン、グルタミ
ン酸及びその誘導体並びにそれらの塩、システイン、シ
スチン、シトルリン、スレオニン、セリン、チロシン、
トリプトファン、テアニン、バリン、ヒスチジン、ヒド
ロキシリジン、ヒドロキシプロリン、ピロリドンカルボ
ン酸及びその塩、プロリン、フェニルアラニン、メチオ
ニン、リジンなどのアミノ酸及びそれらの誘導体又はそ
れらの塩などが挙げられる。
Examples of the humectant include alkaline simple hot spring water, deep water, mucopolysaccharides such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, heparan sulfate, heparin and keratan sulfate or salts thereof, and proteins such as collagen, elastin and keratin. Or their derivatives and their salts, soybean and egg-derived phospholipids, glycolipids,
Ceramide, mucin, honey, erythritol, maltose, maltitol, xylitol, xylose, pentaerythritol, fructose, dextrin and derivatives thereof, mannitol, sorbitol, inositol, trehalose, sugars such as glucose, urea, asparagine, aspartic acid, alanine, arginine , Isoleucine, ortinine, glutamine, glycine, glutamic acid and derivatives thereof and salts thereof, cysteine, cystine, citrulline, threonine, serine, tyrosine,
Examples include tryptophan, theanine, valine, histidine, hydroxylysine, hydroxyproline, pyrrolidonecarboxylic acid and salts thereof, amino acids such as proline, phenylalanine, methionine, and lysine, and derivatives or salts thereof.

【0013】更に保湿剤として、D−パンテノール、ア
ボカド抽出物、アルテア抽出物、アルニカ抽出物、アシ
タバ抽出物、アロエ抽出物、アーモンド油、イナゴマメ
抽出物、イネ抽出物、イチゴ抽出物、ウイキョウ抽出
物、ウコン抽出物、ウスベニアオイ抽出物、サイシン抽
出物、エゴマ油、オウレン抽出物、オリーブ油、オドリ
コソウ抽出物、オトギリソウ抽出物、オウゴン抽出物、
オノニス抽出物、コンブ、マコンブ、ワカメ、ヒジキ、
ヒバマタ、ウミウチワ、マツモ、モズク、イシゲ、ハバ
ノリ、コンブモドキ、フクロノリ、イワヒゲ、カゴメノ
リ、アナメ、スジメ、トロロコンブ、カジメ、ツルアラ
メ、チガイソ、エゾイシゲ、ラッパモク、ホンダワラ、
オオバモク、ジャイアントケルプ等の褐藻類;テング
サ、ヒラクサ、オニクサ、オバクサ、トサカノリ、キリ
ンサイ、ツノマタ、トチヤカ、スギノリ、シキンノリ、
カイノリ、ウスバノリ、ウシケノリ、アサクサノリ、フ
サノリ、カギノリ、ヒビロウド、カタノリ、ムカデノ
リ、マツノリ、トサカマツ、フノリ、イバラノリ、オゴ
ノリ、カイメンソウ、ダルス、イギス、エゴノリ、コノ
ハノリ、ヒメゴケ等の紅藻類;クロレラ、アオノリ、ド
ナリエラ、クロロコッカス、アナアオサ、カワノリ、マ
リモ、シオグサ、カサノリ、フトジュズモ、タマジュズ
モ、ヒトエグサ、アオミドロ等の緑藻類等の海藻抽出物
が挙げられる。
Further, as humectants, D-panthenol, avocado extract, altea extract, arnica extract, ashitaba extract, aloe extract, almond oil, carob extract, rice extract, strawberry extract, fennel extract Thing, turmeric extract, Usniaia oil extract, saishin extract, perilla oil, spinach extract, olive oil, hydrangea extract, hypericum extract, gongon extract,
Ononis extract, Kombu, Macomb, Wakame, Hijiki,
Hibamata, Sea turtle, Matsumo, Mozuku, Ishige, Habanori, Kombumodoki, Fukuronori, Iwahige, Kagomenori, Aname, Sujime, Trolocomb, Kajime, Tsuruarame, Chigaiso, Ezoishige, Lappamok, Hondawara,
Brown algae such as gibbertail, giant kelp, and the like; tengusa, nettle, lynx, oberxa, sasa nori, giraffe, tsunomata, tochiyaka, suginori, shikinori,
Kainori, Usubanori, Ushikenori, Asakusanori, Fusanori, Kaginori, Hibiriudo, Catanori, Mukadenori, Matsunori, Tosakamatsu, Funori, Ibaranori, Ogonori, Caimensou, Dars, Igisu, Egonori, Konohanori, Hydrangea, Hydrangea, etc .; Examples include seaweed extracts such as green algae such as chlorococcus, anaoasa, kawanori, marimo, shiogusa, kasanori, phtojuzmo, tamajuzumo, human enthusiast, and amidro.

【0014】更に保湿剤として、カカオ脂、インチンコ
ウ抽出物、カミツレ抽出物、カラスムギ抽出物、カンゾ
ウ抽出物、キズタ抽出物、キイチゴ抽出物、キンギンカ
抽出物、クマザサ抽出物、クチナシ抽出物、グレープフ
ルーツ抽出物、クジン抽出物、クレソン抽出物、ゲンノ
ショウコ抽出物、ゲンチアナ抽出物、ゴボウ抽出物、コ
ボタンヅル抽出物、コムギ抽出物、ゴマ抽出物、コンフ
リー抽出物、サボテン抽出物、サボンソウ抽出物、サン
ザシ抽出物、サルビア抽出物、ショウガ抽出物、シソ抽
出物、ジオウ抽出物、シア脂、シモツケ抽出物、シャク
ヤク抽出物、シラカバ抽出物、センキュウ抽出物、ゼニ
アオイ抽出物、ソウハクヒ抽出物、タチジャコウソウ抽
出物、大豆抽出物、緑茶、紅茶、烏龍茶等の茶抽出物、
ツバキ抽出物、トウモロコシ抽出物、トウチュウカソウ
抽出物、トルメンチラ抽出物、トウキ抽出物、ドクダミ
抽出物、バクモンドウ抽出物、ハウチマメ抽出物、ハマ
メリス抽出物、ハッカ抽出物、ミドリハッカ抽出物、セ
イヨウハッカ抽出物、パセリ抽出物、バラ抽出物、ヒマ
ワリ抽出物、ヒノキ抽出物、ヘチマ抽出物、ブドウ抽出
物、プルーン抽出物、ブッチャーズブルーム抽出物、ボ
ラージ油、ボタン抽出物、ホホバ油、ボダイジュ抽出
物、ホップ抽出物、マツ抽出物、マロニエ抽出物、マカ
デミアナッツ油、マルメロ抽出物、ムラサキ抽出物、メ
ドウホーム油、メリッサ抽出物、ムクロジ抽出物、ヤグ
ルマソウ抽出物、ユリ抽出物、ユズ抽出物、ユキノシタ
抽出物、ヨクイニン抽出物、羅漢果抽出物、ライム抽出
物、ラベンダー抽出物、リンドウ抽出物、ワレモコウ抽
出物、リンゴ抽出物及びレンゲソウ抽出物等が挙げられ
る。上記に挙げた保湿剤は、一種又は二種以上を適宜選
択して配合することができる。
Further, as humectants, cacao butter, cinnamon extract, chamomile extract, oat extract, licorice extract, kizuta extract, raspberry extract, goldfish, kumazasa extract, gardenia extract, grapefruit extract , Kudin extract, watercress extract, ginger extract, gentian extract, burdock extract, kobotdur extract, wheat extract, sesame extract, comfrey extract, cactus extract, saponosa extract, hawthorn extract, Salvia extract, Ginger extract, Perilla extract, Zio extract, Shea butter, Spiraea extract, Peony extract, Birch extract, Senkyu extract, Zeniai extract, Soybean extract, Scotch extract, Soy extract Products, green tea, black tea, tea extract such as oolong tea,
Camellia extract, corn extract, Eucommia magnolia extract, Tormentilla extract, eucommia extract, Dokudami extract, Bakumondou extract, Hawthorn extract, Hamamelis extract, Mint extract, Green pepper extract, Parsley extract, Parsley Extract, rose extract, sunflower extract, hinoki extract, loofah extract, grape extract, prune extract, butchers bloom extract, borage oil, button extract, jojoba oil, bodaige extract, hop extract, Pine extract, horse chestnut extract, macadamia nut oil, quince extract, murasaki extract, meadow home oil, melissa extract, mukuroji extract, cornflower extract, lily extract, yuzu extract, yukinoshita extract, yoquinin extract , Arhat extract, lime extract, lavender extract , Gentian extract, burnet extract, apple extract and Rengesou extract, and the like. One or two or more of the above-mentioned humectants can be appropriately selected and blended.

【0015】これらの保湿剤のうち、特に好ましいもの
は、皮膚の構成成分であり、従来から化粧料に配合され
ているヒアルロン酸、コンドロイチン硫酸、デルマタン
酸、ヘパラン硫酸、へパリン及びケラタン硫酸等のムコ
多糖類及びそれらの塩、コラーゲン、エラスチン、ケラ
チン等のタンパク質及びそれらの誘導体並びにそれらの
塩、アルテア抽出物、アルニカ抽出物、アシタバ抽出
物、アロエ抽出物、ハウチマメ抽出物、マルメロ抽出物
である。これらの各成分は、その起源について特に制約
はなく、動物由来、植物由来、微生物由来、合成品のい
ずれであってもよい。また、その抽出方法、精製処理方
法等、製法についても特に制約されない。
Of these humectants, particularly preferred are constituents of the skin, such as hyaluronic acid, chondroitin sulphate, dermatanic acid, heparan sulphate, heparin and keratan sulphate which are conventionally incorporated in cosmetics. Mucopolysaccharides and their salts, proteins such as collagen, elastin, and keratin and their derivatives, and their salts, Altea extract, Arnica extract, Ashitaba extract, Aloe extract, Gourd extract, and Quince extract. . Each of these components is not particularly limited with respect to its origin, and may be any of animal origin, plant origin, microorganism origin, and synthetic products. Further, there is no particular limitation on the production method such as the extraction method and the purification treatment method.

【0016】本発明組成物における細胞賦活剤の配合量
(含有量)は、好ましくは0.00001〜10%、よ
り好ましくは0.0001〜5%であり、保湿剤の配合
量(含有量)は、好ましくは0.00001〜70%、
より好ましくは0.0001〜20%である。植物抽出
物等を抽出液のまま用いる場合は乾燥固形分として換算
する。細胞賦活剤及び/又は保湿剤の配合量がこの範囲
内であれば、アセロラ抽出物と組み合わせた場合、皮膚
外用剤中のアセロラ抽出物に影響を及ぼすことがなく、
またアセロラ抽出物が細胞賦活剤及び/又は保湿剤に作
用して、皮膚外用剤は経時安定性も良好で、優れた細胞
賦活効果及び保湿効果を発揮し、かつ優れた使用感を有
する。
The content (content) of the cell activator in the composition of the present invention is preferably 0.00001 to 10%, more preferably 0.0001 to 5%, and the content (content) of the humectant. Is preferably 0.00001 to 70%,
More preferably, it is 0.0001 to 20%. When a plant extract or the like is used as it is as an extract, it is converted as a dry solid content. If the amount of the cell activator and / or humectant is within this range, when combined with the acerola extract, it does not affect the acerola extract in the external preparation for skin,
In addition, the acerola extract acts on the cell activator and / or humectant, and the external preparation for skin has good stability over time, exhibits excellent cell activating effects and moisturizing effects, and has an excellent feeling in use.

【0017】本発明の皮膚外用剤は、常法に従い必須成
分である(A)成分と(B)成分とを通常の皮膚外用剤
として知られる種々の形態の基剤に配合して調製するこ
とができる。皮膚外用剤の形態としては、特に限定され
ず、例えば、乳液、クリーム、化粧水、パック、洗浄料
等のスキンケア化粧料、口紅、ファンデーション等のメ
ーキャップ化粧料、頭皮用化粧料や、軟膏剤、分散液、
クリーム剤、外用液剤などの医薬品等とすることができ
その剤型についても特に制限はなく、固型状、ペースト
状、ムース状、ジェル状、粉末状、溶液系、可溶化系、
乳化系、粉末分散系、多層状とすることができる。
The skin external preparation of the present invention is prepared by blending the essential components (A) and (B) with various types of bases known as ordinary skin external preparations according to a conventional method. Can be. The form of the skin external preparation is not particularly limited, and examples thereof include, for example, emulsions, creams, lotions, packs, skin care cosmetics such as cleaning agents, lipsticks, makeup cosmetics such as foundations, scalp cosmetics, and ointments. Dispersion,
Creams, pharmaceuticals such as liquids for external use, etc., can be used in any form, and there is no particular limitation on the form of the preparation. Solid, paste, mousse, gel, powder, solution, solubilization,
It can be emulsified, powder dispersed, or multilayer.

【0018】また、本発明の皮膚外用剤には、上記
(A)、(B)成分以外に、本発明の効果を損なわない
範囲で、通常、化粧料や医薬部外品、外用医薬品等の製
剤に使用される成分、すなわち、水、油剤、界面活性
剤、金属セッケン、ゲル化剤、粉体、アルコール類、水
溶性高分子、皮膜形成剤、樹脂、紫外線防御剤、包接化
合物、抗菌剤、香料、消臭剤、塩類、PH調整剤、清涼
剤、動物・微生物由来抽出物、植物抽出物、血行促進
剤、収斂剤、抗脂漏剤、活性酸素消去剤、美白剤、抗炎
症剤、角質溶解剤、酵素、ホルモン類、ビタミン類等を
適宜一種又は二種以上添加することができる。
In addition to the components (A) and (B), the external preparation for skin of the present invention usually contains cosmetics, quasi-drugs, and external medicines as long as the effects of the present invention are not impaired. Ingredients used in the formulation, i.e., water, oils, surfactants, metal soaps, gelling agents, powders, alcohols, water-soluble polymers, film-forming agents, resins, UV protection agents, clathrate compounds, antibacterial Agents, fragrances, deodorants, salts, pH regulators, cooling agents, animal / microbial extracts, plant extracts, blood circulation enhancers, astringents, antiseborrheic agents, active oxygen scavengers, whitening agents, anti-inflammatory One, two or more agents, keratolytic agents, enzymes, hormones, vitamins, and the like can be appropriately added.

【0019】[0019]

【実施例】次に参考例、試験例及び実施例を挙げて本発
明を更に詳細に説明するが、本発明はこれらになんら制
約されるものではない。
EXAMPLES Next, the present invention will be described in more detail with reference to Reference Examples, Test Examples and Examples, but the present invention is not limited thereto.

【0020】参考例1. アセロラ抽出物の製造 アセロラ(Acerola,学名 Malpighia emarginata DC)
の果実に精製水を加え、低温下にて1日間抽出を行なっ
た後濾過してアセロラ抽出物を得た(乾燥固形分1.7
%)。
Reference Example 1 Production of acerola extract Acerola (Acerola, scientific name Malpighia emarginata DC)
Purified water was added to the fruit of No. 1 and the mixture was extracted at low temperature for one day and filtered to obtain an acerola extract (dry solid content 1.7).
%).

【0021】参考例2. 胎盤抽出物の製造 妊娠3〜4ヶ月の牛の胎盤1kgを凍結、融解後不純物
を洗浄、除去し、精製水5リットルを加え、減圧、低温
下で3日間抽出し、濾過して胎盤抽出物を得た(乾燥固
形分3.5%)。
Reference Example 2 Production of placental extract 1 kg of placenta of 3-4 month pregnant cows was frozen, thawed, and impurities were washed and removed, 5 liters of purified water was added, extracted under reduced pressure and low temperature for 3 days, and filtered to extract placenta extract. (3.5% dry solids).

【0022】参考例3. オタネニンジン抽出物の製造 オタネニンジンの根250gを細切し、無水エタノール
1リットルを加えてブレンダーを用いて一昼夜撹拌抽出
し、ニンジン抽出物を得た(乾燥固形分1.1%)。
Reference Example 3 Production of Panax ginseng extract 250 g of Panax ginseng root was finely chopped, and 1 liter of absolute ethanol was added thereto, and the mixture was stirred and extracted all day and night using a blender to obtain a carrot extract (dry solid content: 1.1%).

【0023】参考例4. アロエ抽出物の製造 アロエの葉100gを細切後、圧搾し、得られた液汁に
無水エタノール100mlを加え、時々撹拌しながら室
温で抽出し、濾過してアロエ抽出物を得た(乾燥固形分
1.0%)。
Reference Example 4 Production of aloe extract 100 g of aloe leaves are minced and squeezed, and 100 ml of absolute ethanol is added to the obtained sap, extracted at room temperature with occasional stirring, and filtered to obtain an aloe extract (dry solids content). 1.0%).

【0024】参考例5. 乳酸菌抽出物の製造 牛乳タンパク質水溶液1リットルに乳酸かん菌を1%接
種し、40℃で3日間培養する。得られた発酵乳を80
℃で瞬間殺菌し、濾過して乳酸菌抽出物を得た(乾燥固
形分9.5%)。
Reference Example 5 Production of lactic acid bacteria extract 1% of a milk protein aqueous solution is inoculated with 1% of a lactic acid bacterium and cultured at 40 ° C. for 3 days. 80 of the obtained fermented milk
The solution was flash sterilized at ℃ and filtered to obtain a lactic acid bacteria extract (dry solid content: 9.5%).

【0025】参考例6. 海藻抽出物の製造 褐藻類の全草20gを細切し、1,3−ブチレングリコ
ール100mlを加え、時々撹拌しながら室温で3日間
抽出し、濾過して海藻抽出物を得た(乾燥固形分1.2
%)。
Reference Example 6 Manufacture of seaweed extract 20 g of whole plant of brown algae was minced, 100 ml of 1,3-butylene glycol was added, extracted at room temperature for 3 days with occasional stirring, and filtered to obtain a seaweed extract (dry solids content). 1.2
%).

【0026】参考例7. ハウチマメ抽出物の製造 ハウチマメの種子10gを細切し、無水エタノール10
0mlを添加し、時々撹拌しながら室温で5日間抽出
し、濾過してハウチマメ抽出物を得た(乾燥固形分1.
9%)。
Reference Example 7 Production of Hawthorn Extract 10 g of Hawthorn seeds were cut into pieces, and anhydrous ethanol 10 g
0 ml was added, extraction was carried out at room temperature for 5 days with occasional stirring, and filtration was carried out to obtain a bean extract (dry solids 1.
9%).

【0027】参考例8. センブリ抽出物の製造 センブリの全草10gを細切し、無水エタノール100
mlを加え、時々撹拌しながら室温で3日間抽出し、濾
過してセンブリ抽出物を得た(乾燥固形分1.0%)。
Reference Example 8 Production of Assembly Extract 10 g of whole plant of the assembly is cut into pieces, and anhydrous ethanol 100
The mixture was extracted at room temperature for 3 days with occasional stirring, and filtered to obtain an assembly extract (dry solid content: 1.0%).

【0028】試験例1. 線維芽細胞増殖試験 シャーレに培地を適量取り、ヒト新生児線維芽細胞を播
種して、37℃で、二酸化炭素濃度5%中にて静置す
る。翌日、凍結乾燥した表1に示す各細胞賦活剤を濃度
が100μg/ml、アセロラ抽出物は100mg/m
lとなるようにPBS(リン酸緩衝液)に溶解し、培地
の1/10量をシャーレに添加混和する。対照として、
PBSを添加する。各試料に対する細胞数(A)及び対
照の細胞数(B)を測定し、次式により細胞増殖率を算
出した。その結果を表1に示す。 細胞増殖率(%)=(A/B)×100 但し、A:試料添加時の細胞数 B:試料無添加時の細胞数
Test Example 1 Fibroblast Proliferation Test An appropriate amount of medium is taken in a petri dish, and human neonatal fibroblasts are inoculated and allowed to stand at 37 ° C. in a carbon dioxide concentration of 5%. On the next day, the concentration of each of the freeze-dried cell activators shown in Table 1 was 100 μg / ml, and the acerola extract was 100 mg / m2.
The solution is dissolved in PBS (phosphate buffer solution) so as to obtain 1 l, and 1/10 of the medium is added to a Petri dish and mixed. As a control,
Add PBS. The cell number (A) and the control cell number (B) for each sample were measured, and the cell growth rate was calculated by the following equation. Table 1 shows the results. Cell growth rate (%) = (A / B) × 100 where A: number of cells when sample is added B: number of cells when sample is not added

【0029】[0029]

【表1】 [Table 1]

【0030】表1の結果から明らかな如く、アセロラ抽
出物と細胞賦活剤たる胎盤抽出物及びオタネニンジン抽
出物とを組合わせることにより、非常に高い細胞増殖促
進効果が得られる。
As is clear from the results shown in Table 1, a very high cell growth promoting effect can be obtained by combining the acerola extract with the placenta extract and panax ginseng extract which are cell activators.

【0031】実施例1. クリームの調製例 表2に示す組成及び下記製法でクリームを調製し、その
美肌効果を調べた。その結果も併せて表2に示す。
Example 1 Preparation Example of Cream A cream was prepared according to the composition shown in Table 2 and the following method, and its skin effect was examined. Table 2 also shows the results.

【0032】[0032]

【表2】 [Table 2]

【0033】(製法) A.成分(1)〜(5)を混合し、加熱して70℃に保つ。 B.成分(6)、(9)、(11)、(13)及び(14)を混合
し、加熱して70℃に保つ。 C.AにBを加え、混合した後、冷却する。 D.Cに(7)、(8)、(10)及び(12)を加えてクリ
ームを得た。
(Production method) A. Components (1) to (5) are mixed and heated to 70 ° C. B. Components (6), (9), (11), (13) and (14) are mixed and heated to 70 ° C. C. Add B to A, mix and cool. D. C, (7), (8), (10) and (12) were added to obtain a cream.

【0034】(試験方法)24〜45才の健常人15名
をパネルとし、実験的な荒れ肌を惹起する前の肌状態を
ミクロスコープカメラで撮影し、下記基準によりそのス
コアを求めた。実験的な荒れ肌は、上腕屈側部をエーテ
ル、アセトン(1:1)混液で処理することにより惹起
した。さらにその後は、7日間にわたって毎日、朝と夜
の2回被験乳液を塗布し、荒れ肌惹起の1、3、5及び
7日後に前記と同様にして肌状態のスコアを求めた。そ
れらのスコアを平均して、肌荒れの改善並びに防止効果
を評価した。
(Test Method) Using a panel of 15 healthy people aged 24 to 45 years old, the skin condition before causing experimental rough skin was photographed with a microscope camera, and the score was obtained according to the following criteria. Experimental rough skin was caused by treating the upper arm flexion side with a mixture of ether and acetone (1: 1). After that, the test emulsion was applied twice a day, in the morning and at night, for 7 days, and the scores of the skin condition were obtained in the same manner as described above 1, 3, 5 and 7 days after the rough skin was induced. The scores were averaged to evaluate the effect of improving and preventing skin roughness.

【0035】 〔肌状態スコア〕 <スコア> <状 態> 1 肌の皮溝が不鮮明であり、角質のはがれが認められる。 2 肌の皮溝がやや不鮮明であるかまたは一方向性が強い。 3 肌の皮溝は認められるが、浅いかまたは一方向性が強い。 4 肌の皮溝が認められるかまたはやや網目状である。 5 肌の皮溝がはっきり認められるかまたはきれいな網目状である。 上記評価方法により得られた結果を表2に併せて示し
た。表2の結果から明らかな如く、本発明に係わるアセ
ロラ抽出物と保湿剤とを配合したクリームは、これらを
皮膚に適用することにより、肌荒れの発生を防止、改善
することができ、美しい肌とすることができた。
[Skin Condition Score] <Score><State> 1 Skin groove of skin is unclear and exfoliation of keratin is recognized. 2 Skin crevices are slightly unclear or strongly unidirectional. 3 Skin sulcus is recognized but shallow or strongly unidirectional. 4 Skin sulcus is recognized or slightly reticulated. 5 Skin crevices are clearly recognized or have a fine mesh. The results obtained by the above evaluation method are also shown in Table 2. As is clear from the results in Table 2, the cream containing the acerola extract and the humectant according to the present invention can prevent and improve the occurrence of rough skin by applying them to the skin, and can improve the beautiful skin. We were able to.

【0036】実施例2. 乳液の調製例 表3に示す組成の乳液を調製し、その皮膚老化防止効果
を調べた。その結果も併せて表3に示す。
Example 2 Preparation Example of Emulsion An emulsion having the composition shown in Table 3 was prepared and its effect on preventing skin aging was examined. Table 3 also shows the results.

【0037】[0037]

【表3】 [Table 3]

【0038】(製法) A.成分(14)の一部と(6)、(11)及び(13)を加熱
混合し、70℃に保つ。 B.成分(1)〜(5)を加熱混合し、70℃に保つ。 C.上記Bを先のAに加えて混合し、成分(10)を加え
て均一に乳化し、30℃まで冷却して、成分(12)を加
え、均一に混合する。 D.成分(14)の残分に成分(7)〜(9)を混合し、Cに
加え、均一に混合し乳液を得る。
(Production method) A part of the component (14) and (6), (11) and (13) are mixed by heating and kept at 70 ° C. B. Components (1) to (5) are mixed by heating and maintained at 70 ° C. C. Add the above B to the above A, mix and add the component (10) to emulsify uniformly, cool to 30 ° C., add the component (12) and mix uniformly. D. The components (7) to (9) are mixed with the residue of the component (14), added to C, and uniformly mixed to obtain an emulsion.

【0039】(試験方法)被験乳液1品につき26〜5
0才の女性15名をパネルとし、毎日、朝と夜の2回、
12週間にわたって洗顔後に被験乳液の適量を顔面に塗
布した。塗布による皮膚老化防止効果を下の基準によっ
て評価した。
(Test method) 26 to 5 per test emulsion
A panel of 15 0-year-old women, twice daily, morning and night,
After washing the face for 12 weeks, an appropriate amount of the test emulsion was applied to the face. The antiaging effect of the skin by application was evaluated according to the following criteria.

【0040】皮膚老化防止効果: 〔評価〕 〔内 容〕 有 効 肌のはり、つやが改善された。 やや有効 肌のはり、つやがやや改善された。 無 効 使用前と変化なし。 上記評価方法により得られた結果を表3に併せて示す。
表3の結果から明らかな如く、本発明品に係わるアセロ
ラ抽出物と細胞賦活剤とを配合した乳液は、皮膚に適用
することにより、肌のはり、つやが改善され、皮膚の老
化を防止することができた。
Anti-aging effect of skin: [Evaluation] [Contents] Effective Skin peeling and gloss were improved. Slightly effective Skin glue, gloss slightly improved. Ineffective No change from before use. Table 3 also shows the results obtained by the above evaluation method.
As is clear from the results in Table 3, the emulsion containing the acerola extract and the cell activator according to the present invention is applied to the skin to improve the skin's adhesion and gloss, and to prevent skin aging. I was able to.

【0041】 実施例3. 化粧水の調製例 (処方) (%) (1)グリセリン 5.0 (2)1,3−ブチレングリコール 6.5 (3)ポリオキシエチレン(20E.O.)ソルビタン 1.2 モノラウリン酸エステル (4)エチルアルコール 8.0 (5)アセロラ抽出物*1 1.0 (6)マルメロ抽出物*2 1.0 (7)オオムギ抽出物*3 1.0 (8)防腐剤 適量 (9)香料 適量 (10)アルカリ単純温泉水*4 50.0 (11)精製水 残量 *1 参考例1で製造したもの *2 香栄興業社製 *3 テクノーブル社製 *4 丸善製薬社製 (製法) A.成分(3)、(4)、(8)及び(9)を混合溶解する。 B.成分(1)、(2)、(5)〜(7)、(10)及び(11)を
混合溶解する。 C.AとBを混合して均一にし、化粧水を得た。
Example 3. Preparation Example of Lotion (Formulation) (%) (1) Glycerin 5.0 (2) 1,3-butylene glycol 6.5 (3) Polyoxyethylene (20EO) Sorbitan 1.2 Monolaurate ester (4) Ethyl alcohol 8.0 (5) Acerola extract * 1 1.0 (6) Quince extract * 2 1.0 (7) Barley extract * 3 1.0 (8) Preservatives Appropriate amount (9) Fragrance Appropriate amount (10) Alkaline simple hot spring water * 4 50.0 (11) Remaining purified water * 1 Manufactured in Reference Example 1 * 2 Koei Kogyo * 3 Technol * 4. Maruzen Pharmaceutical Co., Ltd. (Production method) Components (3), (4), (8) and (9) are mixed and dissolved. B. Components (1), (2), (5) to (7), (10) and (11) are mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.

【0042】実施例3は、経時安定性に優れ、肌のは
り、つやを改善し、優れた保湿効果及び肌荒れ改善効果
を有する化粧水であった。
Example 3 was a lotion having excellent stability over time, improving skin abrasion and gloss, and having an excellent moisturizing effect and an effect of improving rough skin.

【0043】 実施例4. 軟膏の調製例 (処方) (%) (1)ステアリン酸 18.0 (2)セタノール 4.0 (3)トリエタノールアミン 2.0 (4)グリセリン 5.0 (5)アセロラ抽出物*1 0.01 (6)アシタバ抽出物*2 1.0 (7)ヒアルロン酸ナトリウム*3 1.0 (8)精製水 残量 *1 参考例1で製造したもの *2 一丸ファルコス社製 *3 日光ケミカルズ社製Example 4. Preparation of Ointment (Formulation) (%) (1) Stearic acid 18.0 (2) Cetanol 4.0 (3) Triethanolamine 2.0 (4) Glycerin 5.0 (5 ) Acerola extract * 1 0.01 (6) Ashitaba extract * 2 1.0 (7) Sodium hyaluronate * 3 1.0 (8) Remaining purified water * 1 Produced in Reference Example 1 * 2 Ichimaru Falcos * 3 Nikko Chemicals

【0044】(製法) A.成分(3)、(4)及び(8)の一部を加熱混合し、75
℃に保つ。 B.成分(1)及び(2)を加熱混合し、75℃に保つ。 C.AをBに徐々に加える。 D.Cを冷却しながら(8)の残部で溶解した(5)〜(7)
を加え、軟膏を得た。 実施例4は、優れた保湿効果を有し、肌荒れ改善効果に
有効な軟膏であった。
(Production Method) A. A part of components (3), (4) and (8) are mixed by heating, and
Keep at ° C. B. Heat mix components (1) and (2) and maintain at 75 ° C. C. Add A slowly to B. D. C was dissolved in the remainder of (8) while cooling (5) to (7)
Was added to obtain an ointment. Example 4 was an ointment that had an excellent moisturizing effect and was effective in improving skin roughness.

【0045】 実施例5. パックの調製例 (処方) (%) (1)ポリビニルアルコール 20.0 (2)エタノール 20.0 (3)グリセリン 5.0 (4)カオリン 6.0 (5)アセロラ抽出物*1 0.05 (6)ハウチマメ抽出物*2 3.0 (7)防腐剤 適量 (8)香料 適量 (9)精製水 残量 *1 参考例1で製造したもの *2 参考例7で製造したものEmbodiment 5 Preparation Example of Pack (Formulation) (%) (1) Polyvinyl alcohol 20.0 (2) Ethanol 20.0 (3) Glycerin 5.0 (4) Kaolin 6.0 (5) Acerola extract * 1 0.05 (6) Hazelnut extract * 2 3.0 (7) Preservatives appropriate amount (8) Flavors appropriate amount (9) Purified water balance * 1 Manufactured in Reference Example 1 * 2 Manufactured in Reference Example 7

【0046】(製法) A.成分(1)、(3)、(4)及び(9)を混合し、70℃に
加熱し、撹拌する。 B.成分(2)、(7)及び(8)を混合する。 C.上記Bを先のAに加え、混合した後、冷却して
(5)、(6)を均一に分散してパックを得た。 実施例5は、保湿効果に優れ、肌に潤いを付与するパッ
クであった。
(Production method) Mix components (1), (3), (4) and (9), heat to 70 ° C. and stir. B. Mix components (2), (7) and (8). C. Add the above B to the above A, mix and cool
(5) and (6) were uniformly dispersed to obtain a pack. Example 5 was a pack having an excellent moisturizing effect and giving moisture to the skin.

【0047】 実施例6. 洗浄料の調製例 (処方) (%) (1)ステアリン酸 10.0 (2)パルミチン酸 8.0 (3)ミリスチン酸 12.0 (4)ラウリン酸 4.0 (5)オレイルアルコール 1.5 (6)精製ラノリン 1.0 (7)香料 適量 (8)防腐剤 適量 (9)グリセリン 18.0 (10)水酸化カリウム 6.0 (11)アセロラ抽出物*1 0.5 (12)D−パンテノール*2 0.05 (13)精製水 残量 *1 参考例1で製造したもの *2 シグマ社製Embodiment 6 Preparation Example of Cleaning Agent (Formulation) (%) (1) Stearic acid 10.0 (2) Palmitic acid 8.0 (3) Myristic acid 12.0 (4) Lauric acid 4.0 (5) Oleyl alcohol 5 (6) Refined lanolin 1.0 (7) Perfume proper amount (8) Preservative proper amount (9) Glycerin 18.0 (10) Potassium hydroxide 6.0 (11) Acerola extract * 1 0.5 (12) D-panthenol * 2 0.05 (13) Purified water Remaining amount * 1 Manufactured in Reference Example 1 * 2 Sigma

【0048】(製法) A.成分(9)、(10)及び(13)を混合し、70℃に加
熱する。 B.成分(1)〜(6)、(8)及び(12)し、70℃に加熱
する。 C.上記Bを先のAに加え、しばらく70℃に保ち、反
応が終了後、50℃まで冷却し、成分(7)及び(11)を
加え、冷却して洗浄料を得た。 実施例6は、洗浄後の肌に潤いを付与し、肌のかさつき
を防止する洗浄料であった。
(Production method) A. Mix components (9), (10) and (13) and heat to 70 ° C. B. Combine components (1)-(6), (8) and (12) and heat to 70 ° C. C. The above B was added to the above A, and kept at 70 ° C. for a while. After the reaction was completed, the mixture was cooled to 50 ° C., and the components (7) and (11) were added. Example 6 was a cleaning agent that imparts moisture to the skin after washing and prevents bulkiness of the skin.

【0049】 実施例7. 口紅の製造例 (処方) (%) (1)アセロラ抽出物*1 0.02 (2)γ−リノレン酸*2 0.02 (3)乳酸菌抽出物*3 0.001 (4)赤色202号 0.2 (5)キャンデリラロウ 9.0 (6)固形パラフィン 8.0 (7)ミツロウ 5.0 (8)カルナウバロウ 5.0 (9)ラノリン 11.0 (10)イソプロピルミリステート 10.0 (11)精製ヒマシ油 残量 (12)防腐剤 適量 (13)香料 適量 *1 参考例1で製造したもの *2 出光石油化学社製 *2 参考例5で製造したものExample 7 Production Example of Lipstick (Prescription) (%) (1) Acerola extract * 1 0.02 (2) γ-linolenic acid * 2 0.02 (3) Lactic acid bacterium extract * 30 001 (4) Red No. 202 0.2 (5) Candelilla wax 9.0 (6) Solid paraffin 8.0 (7) Beeswax 5.0 (8) Carnauba wax 5.0 (9) Lanolin 11.0 (10) ) Isopropyl myristate 10.0 (11) Refined castor oil Remaining (12) Preservative proper amount (13) Flavor proper amount * 1 Manufactured in Reference Example 1 * 2 Idemitsu Petrochemical Company * 2 Manufactured in Reference Example 5 thing

【0050】(製法) A.成分(5)〜(12)を加熱溶解後、3本ローラーで練
る。 B.Aに成分(1)〜(3)及び(13)を加えた後、再び3
本ローラーで練る。 C.Bを冷却・成型して口紅を得た。 実施例7は、口唇の荒れを防ぎ、良好な艶、はりをもた
らす口紅であった。
(Production method) After heating and dissolving the components (5) to (12), they are kneaded with three rollers. B. After adding components (1) to (3) and (13) to A,
Knead with this roller. C. B was cooled and molded to obtain a lipstick. Example 7 was a lipstick that prevented roughening of the lips and provided good gloss and abrasion.

【0051】[0051]

【発明の効果】本発明の皮膚外用剤はアセロラ抽出物と
細胞賦活剤及び/又は保湿剤とを配合することにより、
細胞賦活剤及び保湿剤の本来有する薬効の効能を十分に
発揮させることができる。例えば、薬効成分として細胞
賦活剤を併用した皮膚外用剤は、安定で且つ優れた皮膚
老化防止作用を有するため、皮膚のはりやつやを維持
し、シワ形成に高い抑制効果を発揮し、また、保湿剤を
併用した皮膚外用剤は、肌荒れ改善効果及び保湿効果を
発揮するものである。このように、本発明の皮膚外用剤
は、アセロラ抽出物と共に配合することによって細胞賦
活剤及び保湿剤の本来有する薬効を向上させることがで
きるので、美容や医療において極めて有用なものであ
る。
The external preparation for skin of the present invention is obtained by blending an acerola extract with a cell activator and / or a humectant.
The cell activating agent and the moisturizing agent can sufficiently exert their inherent medicinal effects. For example, a skin external preparation combined with a cell activator as a medicinal ingredient has a stable and excellent anti-aging effect on the skin, so that it maintains the skin's shine and luster and exhibits a high inhibitory effect on wrinkle formation, An external preparation for skin combined with a humectant exhibits a skin roughness improving effect and a moisturizing effect. As described above, the skin external preparation of the present invention can be used in cosmetics and medical treatment because it can improve the intrinsic efficacy of the cell activator and the moisturizer by being combined with the acerola extract.

─────────────────────────────────────────────────────
────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成11年8月31日(1999.8.3
1)
[Submission date] August 31, 1999 (1999.8.3)
1)

【手続補正1】[Procedure amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0037[Correction target item name] 0037

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0037】[0037]

【表3】 [Table 3]

フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 17/00 A61K 31/00 617 17/16 617J A61K 35/78 35/78 C (72)発明者 畑 友紀 東京都北区栄町48番18号 株式会社コーセ ー研究本部内 (72)発明者 上原 静香 東京都北区栄町48番18号 株式会社コーセ ー研究本部内 (72)発明者 佐々木 一郎 東京都北区栄町48番18号 株式会社コーセ ー研究本部内 (72)発明者 永峰 賢一 東京都東村山市美住町2−5−1−203 (72)発明者 木藤 孝 埼玉県川口市並木1−21−25−103 Fターム(参考) 4C083 AA031 AA032 AA071 AA082 AA111 AA112 AA121 AA122 AA161 AB032 AB442 AC012 AC022 AC072 AC102 AC122 AC131 AC182 AC242 AC251 AC291 AC301 AC352 AC442 AC471 AC542 AC581 AC611 AC621 AC641 AC792 AC851 AD112 AD212 AD241 AD311 AD332 AD342 AD352 AD391 AD411 AD451 AD512 AD551 AD591 AD592 AD601 AD621 AD631 AD641 BB51 CC02 CC05 CC07 CC13 DD22 DD31 EE12 FF05 4C088 AA04 AA06 AA08 AA12 AA18 AB02 AB03 AB12 AB13 AB14 AB15 AB16 AB18 AB19 AB25 AB26 AB32 AB34 AB38 AB40 AB41 AB45 AB47 AB50 AB51 AB52 AB54 AB55 AB56 AB57 AB59 AB62 AB66 AB67 AB73 AB74 AB76 AB77 AB78 AB81 AB85 AB86 AB88 AD19 BA03 BA06 BA08 CA03 MA08 MA11 MA63 NA14 ZA89 Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat II (reference) A61P 17/00 A61K 31/00 617 17/16 617J A61K 35/78 35/78 C (72) Inventor Yuki Hata Tokyo 48-18 Sakaemachi, Kita-ku Inside Kose Research Laboratory (72) Inventor Shizuka Uehara 48-18 Sakaemachi, Kita-ku, Tokyo Inside (72) Inventor Ichiro Sasaki 48 Sakaemachi Kita-ku, Tokyo No. 18 Kose Research Co., Ltd. (72) Kenichi Nagamine, Inventor 2-5-1-203, Misumi-cho, Higashimurayama-shi, Tokyo (72) Takashi Kito 1-21- 25-103 Namiki, Kawaguchi-shi, Saitama F term (reference) 4C083 AA031 AA032 AA071 AA082 AA111 AA112 AA121 AA122 AA161 AB032 AB442 AC012 AC022 AC072 AC102 AC122 AC131 AC182 AC242 AC251 AC291 AC301 AC352 AC442 AC471 AC542 AC581 AC611 AC621 AC641 AC792 AD851 AD312 AD321 AD312 AD591 AD592 AD601 AD621 AD631 AD641 BB51 CC02 CC05 CC07 CC13 DD 22 DD31 EE12 FF05 4C088 AA04 AA06 AA08 AA12 AA18 AB02 AB03 AB12 AB13 AB14 AB15 AB16 AB18 AB19 AB25 AB26 AB32 AB34 AB38 AB40 AB41 AB45 AB47 AB50 AB51 AB52 AB54 AB55 AB56 AB57 AB59 AB62 AB66 AB67 AB73 AB74 AB76 AB77 AB78 AB81 BA06 BA08 CA03 MA08 MA11 MA63 NA14 ZA89

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】次の成分(A)及び(B)を含有すること
を特徴とする皮膚外用剤。 (A)アセロラ抽出物 (B)細胞賦活剤及び/又は保湿剤
An external preparation for skin, comprising the following components (A) and (B): (A) Acerola extract (B) Cell activator and / or humectant
【請求項2】細胞賦活剤が、デオキシリボ核酸及びその
塩、アデニル酸誘導体及びそれらの塩、リボ核酸及びそ
の塩、サイクリックAMP、サイクリックGMP、フラ
ビンアデニンヌクレオチド、グアニン、アデニン、シト
シン、チミン、キサンチン及びそれらの誘導体であるカ
フェイン、テオフェリン並びにそれらの塩から選ばれる
核酸関連物質;胎盤抽出物、幼牛血液抽出液、血清除蛋
白抽出物、脾臓抽出物、卵成分、鶏冠抽出物、貝殻抽出
物、貝肉抽出物、ローヤルゼリー、シルクプロテイン及
びその分解物又はそれらの誘導体、ヘモグロビン又はそ
の分解物、ラクトフェリン又はその分解物、軟体動物抽
出物、魚肉抽出物から選ばれる動物由来の抽出物;発酵
代謝産物から選ばれる微生物由来の抽出物;ビタミンA
類及びそれらの誘導体並びにそれらの塩、ビタミンB類
及びそれらの誘導体並びにそれらの塩、ビタミンC及び
その誘導体並びにそれらの塩から選ばれるビタミン類;
アスパラガス抽出物、アンズ抽出物、イチョウ抽出物、
オタネニンジン抽出物、オオムギ抽出物、オウバク抽出
物、オレンジ抽出物、キュウリ抽出物、キウイ抽出物、
シイタケ抽出物、スギナ抽出物、センブリ抽出物、タイ
ソウ抽出物、トウキンセンカ抽出物、トウガラシ抽出
物、ニンニク抽出物、ニンジン抽出物、ブクリョウ抽出
物、ブナの芽抽出物、モモ抽出物、レタス抽出物、レモ
ン抽出物、ユーカリ抽出物、霊芝抽出物、ローズマリー
抽出物、ヒノキチオール、セファランチン、ブドウ種子
油から選ばれる植物抽出物;α−及びγ−リノレン酸、
エイコサペンタエン酸及びそれらの誘導体、エストラジ
オール及びその誘導体並びにそれらの塩、グリコール
酸、コハク酸、乳酸、サリチル酸から選ばれる有機酸及
びそれらの誘導体並びにそれらの塩から選ばれたもので
ある請求項1記載の皮膚外用剤。
2. A cell activator comprising deoxyribonucleic acid and salts thereof, adenylic acid derivatives and salts thereof, ribonucleic acids and salts thereof, cyclic AMP, cyclic GMP, flavin adenine nucleotide, guanine, adenine, cytosine, thymine, Nucleic acid related substances selected from xanthine and their derivatives caffeine, theopherin and their salts; placenta extract, calf blood extract, serum deproteinized extract, spleen extract, egg component, cockscomb extract, shell An extract derived from an animal selected from an extract, a shell meat extract, royal jelly, silk protein and its degradation product or a derivative thereof, hemoglobin or its degradation product, lactoferrin or its degradation product, mollusc extract, and fish meat extract; Microbial extract selected from fermentation metabolites; Vitamin A
And their derivatives, their salts, vitamins B and their derivatives, and their salts, vitamin C and its derivatives, and vitamins selected from their salts;
Asparagus extract, apricot extract, ginkgo extract,
Panax ginseng extract, barley extract, oak extract, orange extract, cucumber extract, kiwi extract,
Shiitake extract, horsetail extract, Japanese cabbage extract, Japanese radish extract, Calendula extract, Pepper extract, Garlic extract, Carrot extract, Bulberry extract, Beech bud extract, Peach extract, Lettuce extract , A lemon extract, a eucalyptus extract, a Reishi extract, a rosemary extract, a hinokitiol, a cepharanthin, a plant extract selected from grape seed oil; α- and γ-linolenic acid,
The organic acid selected from eicosapentaenoic acid and derivatives thereof, estradiol and derivatives thereof, and salts thereof, glycolic acid, succinic acid, lactic acid, and salicylic acid, and derivatives thereof and salts thereof. External preparation for skin.
【請求項3】保湿剤がアルカリ単純温泉水、深層水、ム
コ多糖類またはそれらの塩、タンパク質またはそれらの
誘導体並びにそれらの塩、大豆又は卵由来のリン脂質、
糖脂質、セラミド、ムチン、ハチミツ、エリスリトー
ル、マルトース、マルチトール、キシリトール、キシロ
ース、ペンタエリスリトール、フルクトース、デキスト
リン及びその誘導体から選ばれる糖類、尿素、アスパラ
ギン、アスパラギン酸、アラニン、アルギニン、イソロ
イシン、オルチニン、グルタミン、グリシン、グルタミ
ン酸及びその誘導体並びにそれらの塩、システイン、シ
スチン、シトルリン、スレオニン、セリン、チロシン、
トリプトファン、テアニン、バリン、ヒスチジン、ヒド
ロキシリジン、ヒドロキシプロリン、ピロリドンカルボ
ン酸及びその塩、プロリン、フェニルアラニン、メチオ
ニン、リジンから選ばれるアミノ酸及びそれらの誘導体
並びにその塩、D−パンテノール、アボカド抽出物、ア
ルテア抽出物、アルニカ抽出物、アシタバ抽出物、アロ
エ抽出物、アーモンド油、イナゴマメ抽出物、イネ抽出
物、イチゴ抽出物、ウイキョウ抽出物、ウコン抽出物、
ウスベニアオイ抽出物、サイシン抽出物、エゴマ油、オ
ウレン抽出物、オリーブ油、オドリコソウ抽出物、オト
ギリソウ抽出物、オウゴン抽出物、オノニス抽出物、海
藻抽出物、カカオ脂、インチンコウ抽出物、カミツレ抽
出物、カラスムギ抽出物、カンゾウ抽出物、キズタ抽出
物、キイチゴ抽出物、キンギンカ抽出物、クマザサ抽出
物、クチナシ抽出物、グレープフルーツ抽出物、クジン
抽出物、クレソン抽出物、ゲンノショウコ抽出物、ゲン
チアナ抽出物、ゴボウ抽出物、コボタンヅル抽出物、コ
ムギ抽出物、ゴマ抽出物、コンフリー抽出物、サボテン
抽出物、サボンソウ抽出物、サンザシ抽出物、サルビア
抽出物、ショウガ抽出物、シソ抽出物、ジオウ抽出物、
シア脂、シモツケ抽出物、シャクヤク抽出物、シラカバ
抽出物、センキュウ抽出物、ゼニアオイ抽出物、ソウハ
クヒ抽出物、タチジャコウソウ抽出物、大豆抽出物、茶
抽出物、ツバキ抽出物、トウモロコシ抽出物、トウチュ
ウカソウ抽出物、トルメンチラ抽出物、トウキ抽出物、
ドクダミ抽出物、バクモンドウ抽出物、ハウチマメ抽出
物、ハマメリス抽出物、ハッカ抽出物、ミドリハッカ抽
出物、セイヨウハッカ抽出物、パセリ抽出物、バラ抽出
物、ヒマワリ抽出物、ヒノキ抽出物、ヘチマ抽出物、ブ
ドウ抽出物、プルーン抽出物、ブッチャーズブルーム抽
出物、ボラージ油、ボタン抽出物、ホホバ油、ボダイジ
ュ抽出物、ホップ抽出物、マツ抽出物、マロニエ抽出
物、マカデミアナッツ油、マルメロ抽出物、ムラサキ抽
出物、メドウホーム油、メリッサ抽出物、ムクロジ抽出
物、ヤグルマソウ抽出物、ユリ抽出物、ユズ抽出物、ユ
キノシタ抽出物、ヨクイニン抽出物、羅漢果抽出物、ラ
イム抽出物、ラベンダー抽出物、リンドウ抽出物、ワレ
モコウ抽出物、リンゴ抽出物及びレンゲソウ抽出物から
選ばれたものである請求項1記載の皮膚外用剤。
3. The moisturizer is alkaline simple hot spring water, deep water, mucopolysaccharide or a salt thereof, protein or a derivative thereof, a salt thereof, a soybean or egg-derived phospholipid,
Glycolipid, ceramide, mucin, honey, erythritol, maltose, maltitol, xylitol, xylose, pentaerythritol, fructose, dextrin and its derivatives, saccharides, urea, asparagine, aspartic acid, alanine, arginine, isoleucine, ortinine, glutamine , Glycine, glutamic acid and its derivatives and their salts, cysteine, cystine, citrulline, threonine, serine, tyrosine,
Tryptophan, theanine, valine, histidine, hydroxylysine, hydroxyproline, pyrrolidonecarboxylic acid and its salts, proline, phenylalanine, methionine, amino acids selected from lysine and their derivatives and salts thereof, D-panthenol, avocado extract, artea Extract, Arnica extract, Ashitaba extract, Aloe extract, Almond oil, Carob extract, Rice extract, Strawberry extract, Fennel extract, Turmeric extract,
Usvenia mallow extract, saishin extract, perilla oil, spinach extract, olive oil, lycopodium extract, hypericum extract, syrup extract, ononis extract, seaweed extract, cocoa butter, intinko extract, chamomile extract, oat extract , Liquorice extract, Kizuta extract, Rubus extract, Kingfisher extract, Kumazasa extract, Gardenia extract, Grapefruit extract, Kujin extract, Watercress extract, Gennoshoko extract, Gentian extract, Burdock extract, Kobotdur extract, wheat extract, sesame extract, comfrey extract, cactus extract, saponosa extract, hawthorn extract, salvia extract, ginger extract, perilla extract, sage extract,
Shea butter, Spiraea extract, Peony extract, Birch extract, Senkyu extract, Zeniaoi extract, Soybean extract, Scotch extract, Soybean extract, Tea extract, Camellia extract, Maize extract, Eucalyptus extract Stuff, Tormentilla extract, Touki extract,
Dokudami extract, Bakkumondou extract, Hawthorn extract, Hamamelis extract, Mentha extract, Green peppermint extract, Common peppermint extract, Parsley extract, Rose extract, Sunflower extract, Hinoki extract, Loofah extract, Grapes Extract, prune extract, butchers bloom extract, borage oil, button extract, jojoba oil, bodaige extract, hop extract, pine extract, malonie extract, macadamia nut oil, quince extract, purple extract, meadow Home oil, melissa extract, sapling extract, cornflower extract, lily extract, yuzu extract, saxifrage extract, yokuinin extract, arhat extract, lime extract, lavender extract, gentian extract, waremokou extract Selected from apple extract and Astragalus extract Skin external preparation of Motomeko 1, wherein the.
【請求項4】アセロラ抽出物の配合量が乾燥固形分とし
て0.00005〜5重量%であり、細胞賦活剤の配合
量が0.00001〜10重量%である請求項1〜3の
いずれかに記載の皮膚外用剤。
4. The method according to claim 1, wherein the amount of the acerola extract is 0.00005 to 5% by weight as dry solids, and the amount of the cell activator is 0.00001 to 10% by weight. 2. The external preparation for skin according to item 1.
【請求項5】アセロラ抽出物の配合量が乾燥固形分とし
て0.00005〜5重量%であり、保湿剤の配合量が
0.00001〜70重量%である請求項1〜3のいず
れかに記載の皮膚外用剤。
5. The method according to claim 1, wherein the content of the acerola extract is 0.00005 to 5% by weight as dry solids, and the content of the humectant is 0.00001 to 70% by weight. The topical skin preparation according to the above.
JP01653699A 1999-01-26 1999-01-26 External preparation for skin Expired - Fee Related JP3513873B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP01653699A JP3513873B2 (en) 1999-01-26 1999-01-26 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP01653699A JP3513873B2 (en) 1999-01-26 1999-01-26 External preparation for skin

Publications (2)

Publication Number Publication Date
JP2000212027A true JP2000212027A (en) 2000-08-02
JP3513873B2 JP3513873B2 (en) 2004-03-31

Family

ID=11918999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP01653699A Expired - Fee Related JP3513873B2 (en) 1999-01-26 1999-01-26 External preparation for skin

Country Status (1)

Country Link
JP (1) JP3513873B2 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002138028A (en) * 2000-10-30 2002-05-14 Pias Arise Kk Skin care preparation for external use and method for preparing the same
JP2002302401A (en) * 2001-04-02 2002-10-18 Okinawa Prefecture Deep Ocean Water Development Coop Society Freshening liquid and method for producing the same
WO2003015724A1 (en) * 2001-08-21 2003-02-27 Shiseido Company, Ltd. Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof
JP2003292430A (en) * 2002-04-01 2003-10-15 Noevir Co Ltd Skin care preparation
WO2004016236A1 (en) * 2002-08-14 2004-02-26 Fancl Corporation Cosmetics
JP2004339140A (en) * 2003-05-15 2004-12-02 Kanebo Ltd Skin cosmetic
WO2005105126A1 (en) * 2004-04-30 2005-11-10 National University Corporation NARA Institute of Science and Technology Active oxygen eliminator and moisturizer containing wild watermelon extract
WO2006067985A1 (en) * 2004-12-22 2006-06-29 Nichirei Biosciences Inc. Novel polyphenol glycoside derived from acerola
US7090872B2 (en) 2002-11-25 2006-08-15 Nichirei Biosciences Inc. Antioxidant, skin preparation for external use, cosmetic and food
JP2008115098A (en) * 2006-11-02 2008-05-22 Hoyu Co Ltd Humectant for skin and skin care preparation
JP2009040757A (en) * 2007-08-10 2009-02-26 Maruzen Pharmaceut Co Ltd Agent promoting laminin 5 production, agent normalizing dermal basement membrane, and agent promoting recovery of skin lesion
JP2009046425A (en) * 2007-08-20 2009-03-05 Noevir Co Ltd Skin care preparation for external use and humectant
JP2009073777A (en) * 2007-09-21 2009-04-09 Kao Corp Cosmetic
ITMI20090521A1 (en) * 2009-04-01 2010-10-02 Salati Gian Luca Lamberto COSMETIC COMPOSITION WITH MOISTURIZING ACTIVITY AND FAVORABLE SKIN ELECTICITY
JP2011207769A (en) * 2010-03-29 2011-10-20 Arubion:Kk Cosmetic and skin care preparation for external use
JP2012056933A (en) * 2010-09-13 2012-03-22 Maruzen Pharmaceut Co Ltd Elastin production promoter
WO2012124738A1 (en) * 2011-03-15 2012-09-20 株式会社資生堂 Bleomycin hydrolase production promoting agent
CN103222943A (en) * 2011-09-27 2013-07-31 沈志荣 Preparation method for instantaneous penetration skin regeneration water composition containing pansy flower extract, guava extract and hydrolyzed pearl
CN103222946A (en) * 2011-09-27 2013-07-31 沈志荣 Preparation method for instantaneous penetration skin regeneration water composition containing American elderberry extract, guava extract and hydrolyzed pearl
CN103230352A (en) * 2011-09-27 2013-08-07 沈志荣 Method for preparing plant extract and hydrolyzed pearl-containing toner composition
CN103239371A (en) * 2011-09-27 2013-08-14 沈志荣 Preparation method of toning lotion composition containing chamomile extract and panax ginseng extract
CN103340811A (en) * 2011-09-27 2013-10-09 沈志荣 Lotion composition containing sambucus canadensis extracts, pansy extracts and hydrolyzed pearls
CN103340810A (en) * 2011-09-27 2013-10-09 沈志荣 Lotion composition containing coconut/seaweed composite extracts, ginseng root extracts and hydrolyzed pearls
CN104940047A (en) * 2015-06-25 2015-09-30 广州保税区雅兰国际化妆品有限公司 Cosmetic composition with moisturizing function and preparation method thereof
CN105213256A (en) * 2015-10-08 2016-01-06 青岛海之源智能技术有限公司 A kind of Shu Min dispels red toner/smoothing toner and preparation method thereof
CN105853327A (en) * 2016-04-11 2016-08-17 吴金霞 Traditional Chinese medicine cosmetic capable of tendering skin and maintaining youth
JP2018052904A (en) * 2016-09-30 2018-04-05 小林製薬株式会社 External composition
KR20190074880A (en) * 2017-12-20 2019-06-28 청담씨디씨제이앤팜 유한책임회사 Method for production of Malpighia emarginata fruit extract without mass destruction of effective compound and cosmetic composition with the extract
CN112870126A (en) * 2021-03-06 2021-06-01 广州中草世家化妆品有限公司 Efficient moisturizing composition rich in ginseng essence and preparation method and application thereof
CN115590772A (en) * 2022-10-31 2023-01-13 北京茂思商贸有限公司(Cn) Double-layer essential oil with anti-wrinkle repairing effect and preparation method thereof

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002138028A (en) * 2000-10-30 2002-05-14 Pias Arise Kk Skin care preparation for external use and method for preparing the same
JP2002302401A (en) * 2001-04-02 2002-10-18 Okinawa Prefecture Deep Ocean Water Development Coop Society Freshening liquid and method for producing the same
WO2003015724A1 (en) * 2001-08-21 2003-02-27 Shiseido Company, Ltd. Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof
KR100892888B1 (en) * 2001-08-21 2009-04-15 가부시키가이샤 시세이도 Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof
JP2003292430A (en) * 2002-04-01 2003-10-15 Noevir Co Ltd Skin care preparation
WO2004016236A1 (en) * 2002-08-14 2004-02-26 Fancl Corporation Cosmetics
US7090872B2 (en) 2002-11-25 2006-08-15 Nichirei Biosciences Inc. Antioxidant, skin preparation for external use, cosmetic and food
JP2004339140A (en) * 2003-05-15 2004-12-02 Kanebo Ltd Skin cosmetic
WO2005105126A1 (en) * 2004-04-30 2005-11-10 National University Corporation NARA Institute of Science and Technology Active oxygen eliminator and moisturizer containing wild watermelon extract
JP2006176454A (en) * 2004-12-22 2006-07-06 Nichirei Biosciences Inc New polyphenol glycoside derived from acerola
WO2006067985A1 (en) * 2004-12-22 2006-06-29 Nichirei Biosciences Inc. Novel polyphenol glycoside derived from acerola
JP4532257B2 (en) * 2004-12-22 2010-08-25 株式会社ニチレイバイオサイエンス A novel polyphenol glycoside derived from acerola
US7935673B2 (en) 2004-12-22 2011-05-03 Nichirei Biosciences, Inc. Polyphenol glycoside isolated from acerola
JP2008115098A (en) * 2006-11-02 2008-05-22 Hoyu Co Ltd Humectant for skin and skin care preparation
JP2009040757A (en) * 2007-08-10 2009-02-26 Maruzen Pharmaceut Co Ltd Agent promoting laminin 5 production, agent normalizing dermal basement membrane, and agent promoting recovery of skin lesion
JP2009046425A (en) * 2007-08-20 2009-03-05 Noevir Co Ltd Skin care preparation for external use and humectant
JP2009073777A (en) * 2007-09-21 2009-04-09 Kao Corp Cosmetic
ITMI20090521A1 (en) * 2009-04-01 2010-10-02 Salati Gian Luca Lamberto COSMETIC COMPOSITION WITH MOISTURIZING ACTIVITY AND FAVORABLE SKIN ELECTICITY
JP2011207769A (en) * 2010-03-29 2011-10-20 Arubion:Kk Cosmetic and skin care preparation for external use
JP2012056933A (en) * 2010-09-13 2012-03-22 Maruzen Pharmaceut Co Ltd Elastin production promoter
WO2012124738A1 (en) * 2011-03-15 2012-09-20 株式会社資生堂 Bleomycin hydrolase production promoting agent
JP2012193136A (en) * 2011-03-15 2012-10-11 Shiseido Co Ltd Bleomycin hydrolase production promoting agent
CN105770077A (en) * 2011-03-15 2016-07-20 株式会社资生堂 Bleomycin Hydrolase Production Promoting Agent
CN103340810A (en) * 2011-09-27 2013-10-09 沈志荣 Lotion composition containing coconut/seaweed composite extracts, ginseng root extracts and hydrolyzed pearls
CN103222943A (en) * 2011-09-27 2013-07-31 沈志荣 Preparation method for instantaneous penetration skin regeneration water composition containing pansy flower extract, guava extract and hydrolyzed pearl
CN103239371A (en) * 2011-09-27 2013-08-14 沈志荣 Preparation method of toning lotion composition containing chamomile extract and panax ginseng extract
CN103340811A (en) * 2011-09-27 2013-10-09 沈志荣 Lotion composition containing sambucus canadensis extracts, pansy extracts and hydrolyzed pearls
CN103222946A (en) * 2011-09-27 2013-07-31 沈志荣 Preparation method for instantaneous penetration skin regeneration water composition containing American elderberry extract, guava extract and hydrolyzed pearl
CN103230352A (en) * 2011-09-27 2013-08-07 沈志荣 Method for preparing plant extract and hydrolyzed pearl-containing toner composition
CN104940047A (en) * 2015-06-25 2015-09-30 广州保税区雅兰国际化妆品有限公司 Cosmetic composition with moisturizing function and preparation method thereof
CN105213256A (en) * 2015-10-08 2016-01-06 青岛海之源智能技术有限公司 A kind of Shu Min dispels red toner/smoothing toner and preparation method thereof
CN105853327A (en) * 2016-04-11 2016-08-17 吴金霞 Traditional Chinese medicine cosmetic capable of tendering skin and maintaining youth
JP2018052904A (en) * 2016-09-30 2018-04-05 小林製薬株式会社 External composition
KR20190074880A (en) * 2017-12-20 2019-06-28 청담씨디씨제이앤팜 유한책임회사 Method for production of Malpighia emarginata fruit extract without mass destruction of effective compound and cosmetic composition with the extract
KR102022068B1 (en) 2017-12-20 2019-09-18 청담씨디씨제이앤팜 유한책임회사 Method for production of Malpighia emarginata fruit extract without mass destruction of effective compound and cosmetic composition with the extract
CN112870126A (en) * 2021-03-06 2021-06-01 广州中草世家化妆品有限公司 Efficient moisturizing composition rich in ginseng essence and preparation method and application thereof
CN115590772A (en) * 2022-10-31 2023-01-13 北京茂思商贸有限公司(Cn) Double-layer essential oil with anti-wrinkle repairing effect and preparation method thereof

Also Published As

Publication number Publication date
JP3513873B2 (en) 2004-03-31

Similar Documents

Publication Publication Date Title
JP2000212027A (en) Preparation for external use for skin
JP2000119155A (en) Skin lotion
JP2000327552A (en) Skin preparation for external use
JP2000119156A (en) Skin lotion
JP2000229827A (en) Skin lotion
JP2002326922A (en) Skin external preparation
JPH10182412A (en) External-use medical preparation
JPH09291011A (en) Composition suitable for eternal use
JP2001031580A (en) Preparation for external use for skin
JP2002128651A (en) Photoaging inhibitor and skin care preparation characterized by comprising the same
JP2001031558A (en) Skin lotion
JP2000256131A (en) Tyrosinase production inhibitor and skin lotion containing the same
JP2002212087A (en) Skin care preparation
JP2004010526A (en) Skin care preparation for external use
JP2003063925A (en) Skin care preparation
JPH09183718A (en) Composition suitable for external application
JP2002332224A (en) Anti-ageing skin care preparation and anti-ageing skin care preparation composition
JP2002138027A (en) Skin care preparation for external use
JP2002265348A (en) Composition for external use
JP2000327525A (en) Skin preparation for external use
JPH10114670A (en) Composition suitable for external use
JP3513871B2 (en) Skin whitening external preparation
JP2002205916A (en) Cosmetic
JP2002275018A (en) Skin care preparation
JP4713032B2 (en) Skin preparation

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040105

R150 Certificate of patent or registration of utility model

Ref document number: 3513873

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130123

Year of fee payment: 9

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130123

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160123

Year of fee payment: 12

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees